<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Virginia Tech research &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/virginia-tech-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 15 Oct 2025 09:32:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Virginia Tech research &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>How Drunk Do You Feel? Virginia Tech Researchers Find Ozempic, Wegovy May Help Reduce Alcohol Consumption</title>
		<link>https://bioengineer.org/how-drunk-do-you-feel-virginia-tech-researchers-find-ozempic-wegovy-may-help-reduce-alcohol-consumption/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 15 Oct 2025 09:31:55 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[alcohol use disorder]]></category>
		<category><![CDATA[GLP-1 receptor agonists]]></category>
		<category><![CDATA[metabolic disorder treatments]]></category>
		<category><![CDATA[pharmacological alcohol modulation]]></category>
		<category><![CDATA[Virginia Tech research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/how-drunk-do-you-feel-virginia-tech-researchers-find-ozempic-wegovy-may-help-reduce-alcohol-consumption/</guid>

					<description><![CDATA[A pioneering study from the Fralin Biomedical Research Institute at Virginia Tech Carilion (VTC) sheds new light on the potential interplay between medications commonly prescribed for diabetes and obesity and alcohol metabolism in the human body. These medications, known as GLP-1 receptor agonists—including semaglutide, tirzepatide, and liraglutide, widely marketed under brands such as Ozempic and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">281236</post-id>	</item>
	</channel>
</rss>
